Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Search results for:

rivastigmine

rivastigmine
  • Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Exelon CAPSULE, ORAL 1.5 mg, 3 mg      
Exelon FILM, EXTENDED RELEASE, TRANSDERMAL 4.6 mg/24 hr, 9.5 mg/24 hr, 13.3 mg/24 hr      
VIEW MORE Parasympathomimetic (Cholinergic) Agents
Comments:

 

 

Shortage Strategy (physostigmine supply exhausted as of May 2026):

In the event that physostigmine is unavailable, consider use of rivastigmine orally/enterally [see anticholinergic toxicity for dosing strategies] in addition to supportive care.

 

Reviewed: September 25, 2007 (Exelon patch)

Last updated: May. 13, 2026






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved